Investigational Site Number 840020

Washington D.C., District of Columbia 20037

0 studies enrolling now · 1 studies all time

What they study most

Neoplasm Malignant

Studies at this site

• Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment — Completed